Intech Investment Management LLC decreased its holdings in Genpact Limited (NYSE:G - Free Report) by 50.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 66,680 shares of the business services provider's stock after selling 67,975 shares during the period. Intech Investment Management LLC's holdings in Genpact were worth $3,359,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Cornerstone Planning Group LLC bought a new position in Genpact in the 1st quarter worth $27,000. Richardson Financial Services Inc. purchased a new stake in shares of Genpact during the 1st quarter valued at about $35,000. SVB Wealth LLC purchased a new stake in shares of Genpact during the 1st quarter valued at about $41,000. Kestra Investment Management LLC purchased a new stake in shares of Genpact during the 1st quarter valued at about $56,000. Finally, Global X Japan Co. Ltd. bought a new position in shares of Genpact in the 1st quarter worth approximately $57,000. 96.03% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of equities research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Genpact in a research note on Thursday, July 17th. They set a "hold" rating and a $47.00 target price on the stock. Mizuho raised their target price on shares of Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 1st. JPMorgan Chase & Co. reduced their price objective on shares of Genpact from $55.00 to $50.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 20th. Wall Street Zen cut shares of Genpact from a "buy" rating to a "hold" rating in a research report on Friday, September 5th. Finally, Needham & Company LLC lifted their price objective on shares of Genpact from $50.00 to $53.00 and gave the company a "buy" rating in a research report on Friday, August 8th. Three analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $52.29.
Read Our Latest Analysis on G
Insider Buying and Selling at Genpact
In other news, SVP Piyush Mehta sold 76,902 shares of the business's stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the transaction, the senior vice president owned 134,880 shares of the company's stock, valued at approximately $5,743,190.40. The trade was a 36.31% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Balkrishan Kalra sold 55,000 shares of the company's stock in a transaction dated Thursday, September 11th. The shares were sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the completion of the transaction, the chief executive officer directly owned 295,246 shares in the company, valued at $12,801,866.56. The trade was a 15.70% decrease in their position. The disclosure for this sale can be found here. 3.07% of the stock is currently owned by insiders.
Genpact Trading Down 1.1%
Shares of G traded down $0.44 during trading hours on Thursday, reaching $41.33. 1,277,801 shares of the company traded hands, compared to its average volume of 1,616,540. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.32. Genpact Limited has a 12-month low of $37.82 and a 12-month high of $56.76. The stock's fifty day moving average price is $44.11 and its 200 day moving average price is $45.61. The firm has a market cap of $7.20 billion, a price-to-earnings ratio of 13.73, a PEG ratio of 1.43 and a beta of 0.92.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, beating analysts' consensus estimates of $0.85 by $0.03. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The business had revenue of $1.25 billion for the quarter, compared to analysts' expectations of $1.23 billion. During the same period last year, the business earned $0.79 EPS. The company's revenue was up 6.6% compared to the same quarter last year. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. Sell-side analysts forecast that Genpact Limited will post 3.21 earnings per share for the current year.
Genpact Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, September 11th will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Thursday, September 11th. Genpact's payout ratio is 22.59%.
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.